Skip to main content
Log in

Gamma secretase–mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke

  • Brief Communication
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Abstract

Mice transgenic for antisense Notch and normal mice treated with inhibitors of the Notch-activating enzyme γ-secretase showed reduced damage to brain cells and improved functional outcome in a model of focal ischemic stroke. Notch endangers neurons by modulating pathways that increase their vulnerability to apoptosis, and by activating microglial cells and stimulating the infiltration of proinflammatory leukocytes. These findings suggest that Notch signaling may be a therapeutic target for treatment of stroke and related neurodegenerative conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Evidence for involvement of γ-secretase and Notch signaling in ischemic stroke.
Figure 2: Notch signaling promotes neuronal apoptosis and enhances leukocyte infiltration in cerebral ischemia.

Similar content being viewed by others

References

  1. Costa, R.M., Drew, C. & Silva, A.J. Trends Neurosci. 28, 429–435 (2005).

    Article  CAS  Google Scholar 

  2. Selkoe, D. & Kopan, R. Annu. Rev. Neurosci. 26, 565–597 (2003).

    Article  CAS  Google Scholar 

  3. Yoon, K. & Gaiano, N. Nat. Neurosci. 8, 709–715 (2005).

    Article  CAS  Google Scholar 

  4. Sugawara, T. et al. NeuroRx 1, 17–25 (2004).

    Article  Google Scholar 

  5. Frijns, C.J. & Kappelle, L.J. Stroke 33, 2115–2122 (2002).

    Article  CAS  Google Scholar 

  6. Wang, Y. et al. Proc. Natl. Acad. Sci. USA 101, 9458–9462 (2004).

    Article  CAS  Google Scholar 

  7. Dovey, H.F. et al. J. Neurochem. 76, 173–181 (2001).

    Article  CAS  Google Scholar 

  8. Milano, J. et al. Toxicol. Sci. 82, 341–358 (2004).

    Article  CAS  Google Scholar 

  9. Ciofani, M. & Zuniga-Pflucker, J.C. Nat. Immunol. 6, 881–888 (2005).

    Article  CAS  Google Scholar 

  10. Berezovska, O. et al. Neuroscience 93, 433–439 (1999).

    Article  CAS  Google Scholar 

  11. Ishikura, N. et al. Proc. Natl. Acad. Sci. USA 102, 886–891 (2005).

    Article  CAS  Google Scholar 

  12. Mattson, M.P. Nat. Rev. Mol. Cell Biol. 1, 120–129 (2000).

    Article  CAS  Google Scholar 

  13. Prunell, G.F., Arboleda, V.A. & Troy, C.M. Curr. Drug Targets CNS Neurol. Disord. 4, 51–61 (2005).

    Article  CAS  Google Scholar 

  14. Eagar, T.N. et al. Immunity 20, 407–415 (2004).

    Article  CAS  Google Scholar 

  15. Pollack, S.J. & Lewis, H. Curr. Opin. Investig. Drugs 6, 35–47 (2005).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank H. Zhu for technical assistance and B. De Strooper for providing presenilin-deficient cells. This research was supported by the National Institute on Aging Intramural Research Program of the US National Institutes of Health.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark P Mattson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Fig. 1

Notch signaling promotes neuronal cell death. (PDF 637 kb)

Supplementary Methods (PDF 142 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arumugam, T., Chan, S., Jo, DG. et al. Gamma secretase–mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke. Nat Med 12, 621–623 (2006). https://doi.org/10.1038/nm1403

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1403

  • Springer Nature America, Inc.

This article is cited by

Navigation